Catch up on today’s top five analyst downgrades with this list compiled by The Fly: 1. Rigel Pharmaceuticals (RIGL) downgraded to Neutral from Overweight at JPMorgan with analyst Tessa Romero saying she sees long-term upside potential in the shares, more near term, Romero is more cautious on the commercial outlook. 2. Elanco (ELAN) double downgraded to Underweight from Overweight at Barclays with analyst Balaji Prasad saying while he still sees a “stronger entity emerging” post the Bayer integration, he thinks any material improvements in the company’s portfolio, operating profit and returns profile will take longer than anticipated. 3. Albemarle (ALB) downgraded to Hold from Buy at Vertical Research with analyst Kevin McCarthy stating that he thinks positives are likely priced in given the current share price. 4. Mattel (MAT) downgraded to Hold from Buy at Jefferies with analyst Stephanie Wissink saying while not turning more bearish, she prefers to pause with the stock within about 5% of her price target. 5. BorgWarner (BWA) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he sees challenging trade-offs of growth-over-market versus margins as highly profitable ICE solutions are replaced by more commoditized, solid state e-solutions. This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post